Please Wait
Applying Filters...

Information, Expiry & Status of FDA Orange Book Patents covering 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha)

Menu
$ API Ref.Price (USD/KG) : 7,465Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2APIL

02 7SUMITOMO PHARMA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Left Arrow
Right Arrow

01

arrow
AAPS 2024
Not Confirmed

APIL

Country
arrow
AAPS 2024
Not Confirmed

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE

US Patent Number : 7704984

Drug Substance Claim :

Drug Product Claim :

Application Number : 22501

Patent Use Code : U-1090

Delist Requested :

Patent Use Description : LO LOESTRIN FE IS INDI...

Patent Expiration Date : 2029-02-02

blank

02

arrow
AAPS 2024
Not Confirmed

APIL

Country
arrow
AAPS 2024
Not Confirmed

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE

US Patent Number : 7704984

Drug Substance Claim :

Drug Product Claim :

Application Number : 204654

Patent Use Code : U-1

Delist Requested :

Patent Use Description : PREVENTION OF PREGNANC...

Patent Expiration Date : 2029-02-02

blank

03

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX

US Patent Number : 11793812

Drug Substance Claim :

Drug Product Claim :

Application Number : 214846

Patent Use Code : U-2360

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-05-03

blank

04

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX

US Patent Number : 9346822

Drug Substance Claim :

Drug Product Claim :

Application Number : 214846

Patent Use Code : U-3129

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-02-17

blank

05

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX

US Patent Number : 11033551

Drug Substance Claim :

Drug Product Claim :

Application Number : 214846

Patent Use Code : U-3129

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-09-29

blank

06

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX

US Patent Number : 11957684

Drug Substance Claim :

Drug Product Claim :

Application Number : 214846

Patent Use Code : U-3129

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-09-29

blank

07

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX

US Patent Number : 11795178

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 214846

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-09-27

blank

08

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX

US Patent Number : 7300935

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 214846

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-01-28

blank

09

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX

US Patent Number : 8058280

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 214846

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-01-28

blank